Healthcare Professionals
Consulta CRT-P
Cardiac Resynchronization Therapy Pacemaker
You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic Canada does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
Healthcare Professionals
Cardiac Resynchronization Therapy Pacemaker
The Medtronic Consulta® CRT-P system is designed specifically for patients who are candidates for cardiac resynchronization therapy and indicated for a bradycardia pacemaker.
Consulta® CRT-P combines industry-leading pacing technology, cardiac resynchronization therapy, and Medtronic exclusive features for proactive heart failure management.
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
Medtronic Exclusives | |||||
---|---|---|---|---|---|
Exclusive | Exclusive | Exclusive | |||
OptiVol Monitoring |
5 Pacing Vectors |
Complete Capture Management |
Leadless ECG |
CareLink Network |
|
Consulta® CRT-P Pacemaker |
x | x | x | x | x |
Heart Failure Diagnostics
Medtronic heart failure diagnostic tools help clinicians identify patients at risk of heart failure hospitalization:1-7
OptiVol® Fluid Status Monitoring uses intrathoracic impedance to indicate fluid status in heart failure patients.
CardioSight Reader helps clinicians quickly identify issues and respond to significant clinical events in heart failure patients.
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. August 9, 2005; 112(6):841-848.
Vollmann D, Nägele H, Schauert P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. August 2007; 28(15):1835-1840.
Catanzariti D, Lunati M, Landolina M, et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. PACE. March 2008; 32(3):363-370.
Perego GB, Landolina M, Vergara G, et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. J Interv Card Electrophysiol. December 2008; 23(3):235-242.
Small RS, Wickemeyer W, Germany R, et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. August 2009;15(6):475-481.
Abraham WT. Superior performance of intrathoracic impedance-derived fluid index versus daily weight monitoring in heart failure patients. Results of the Fluid Accumulation Status Trial. Late Breaking Clinical Trials. J Card Fail. Vol. 15 No. 9 2009, p 813.
Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients with Heart Failure) study. J Am Coll Cardiol. April 27, 2010;55(17):1803-1810.
Multiple pacing vectors:
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
Ensure CRT Suite
Exclusive Complete Capture Management™ ensures capture in all chambers.
Medtronic AT/AF intervention algorithms:
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
Crossley GH, Mead H, Kleckner K, et al. Automatic left ventricular capture management. Pacing Clin Electrophysiol. October 2007;30(10): 1190-1200.
Medtronic’s Leadless ECG Waveform offers patient comfort and convenience
All patient and clinic data displayed are fictitious and for demonstration purposes only.
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
*Available through CareLink Network only
15 cc,* 26 g
57 x 59 x 6 mm
8.1 years† longevity
See the Medtronic Consulta CRT-P Pacemaker Clinician Manual.
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features and may impact longevity.
Bores open
600 ohms; 100% atrial pacing; 100% BiV pacing; A and RV Amp = 2.5 V;
LV Amp = 3.0 V; Pre-EGM Storage ON